Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

Share Price is delayed by 15 minutes
Get Live Data
2,510.00    0.00 (0.00%)
Bid:
2,246.00
Ask:
2,800.00
Spread: 554.00 (24.666%)
Market Cap: £7.53b
SMIN Live PriceLast checked at - London Stock Exchange

Intraday Smiths Group Share Chart

SHARE BUYBACK PROGRAMME

12 Oct 2022 09:30

RNS Number : 6308C
Smiths Group PLC
12 October 2022
ย 

12 October 2022

ย 

SMITHS GROUP PLC

ย 

SHARE BUYBACK PROGRAMME

ย 

Smith Group plc ("Smiths" or the "Company") announces that, in connection with the share buyback programme (the "Programme") of up to ยฃ742 million which it announced on 11 November 2021, Smiths will commence the fifth tranche of the Programme to purchase ordinary shares in the capital of the Company (the "Ordinary Shares") with a value of up to ยฃ144 million, subject to remaining within the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its General Meeting on 17 November 2021 (the 2021 GM authority is for a maximum of 59,435,913 shares).

ย 

The fifth tranche will commence on 17 October 2022 and will conclude no later than 31 March 2023 or once the ยฃ742 million programme has completed (the "Engagement Period"). The purpose of the Programme is to reduce the share capital of Smiths.

ย 

As previously announced, the fourth tranche of the Programme will end on 15 October 2022.

ย 

The Company has entered into an agreement with Goldman Sachs International ("Goldman Sachs") under which Goldman Sachs will manage the fifth tranche of the Programme. Goldman Sachs will carry out the instruction through the acquisition of Ordinary Shares in the Company for subsequent repurchase and cancellation by the Company. This arrangement is in accordance with the Company's general authority to repurchase Ordinary Shares, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

ย 

Goldman Sachs may undertake transactions in the Company's Ordinary Shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the Engagement Period in order to manage its market exposure under the Programme. Disclosure of such transactions will not be made by Goldman Sachs as a result of or as part of the Programme, but Goldman Sachs will continue to make any disclosures it is otherwise legally required to make.

ย 

ย 

Enquiries:

ย 

Jemma Spalton, Director of Communications & Investor Relations+44 (0)20 7004 1600

Jemma.splaton@smiths.com

Matthew Whyte, Company Secretary+44 (0)20 7004 1600Matthew.whyte@smiths.com

ย 

ย 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

ย 

About Smiths Group

ย 

For over 170 years,ย Smiths Groupย has been pioneering progress by improving the world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient and better-connected world, across four major global markets: Energy, General Industry, Security & Defence, and Aerospace. Listed on theย London Stock Exchange, Smiths employs c. 14,600 colleagues in over 50 countries. For more information visitย www.smiths.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
POSEAPEAFFPAFEA
Date   Source Headline
1st Nov 202411:30 amRNSDirector/PDMR Shareholding
1st Nov 20249:00 amRNSBlock listing Interim Review
16th Oct 20243:30 pmRNSDirector/PDMR Shareholding
10th Oct 202411:00 amRNSAnnual Financial Report
2nd Oct 20244:32 pmRNSDirector/PDMR Shareholding
1st Oct 20243:33 pmRNSTotal Voting Rights
24th Sep 20247:01 amRNSSmiths Group Full Year 24 results
24th Sep 20247:00 amRNSSmiths announces two North American acquisitions
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 202411:02 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20243:30 pmRNSDirector/PDMR Shareholding
1st Aug 20242:18 pmRNSTotal Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202410:36 amRNSTransaction in Own Shares
17th Jul 20247:00 amRNSSmiths sells 1.2m shares in ICU Medical Inc
12th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.